Aytu Biopharma Inc AYTU

US Pharmaceuticals

$2.28 ▼ -1.30% ($-0.03)

🎈 Low Float

Open $2.28

Prev Close $2.31

Day Range $2.21 – $2.29

52W Range $1.65 – $3.07

Market Cap $24.78M

Beta 0.20

EPS (TTM) $-1.49

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2017-10-20
Shares Out.	10,730,000
Website	aytubio.com/ ↗
Phone	13026365400
Employees	76
Revenue	$16.1M
Gross Profit	$10.4M
Net Income	-$15,000
Free Cash Flow	$3.3M
Total Assets	$105.0M
Total Liabilities	$69.7M
Equity	$35.3M

About Aytu Biopharma Inc

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Aytu Biopharma Inc is a publicly traded company under the ticker symbol AYTU on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.